Boehringer Ingelheim initiates interchangeability trial of BI 695501 and Humira

Boehringer Ingelheim has initiated patient enrolment in an interchangeability clinical trial (VOLTAIRE-X) of its product candidate BI 695501 and the US-marketed formulation of 40mg/0.8mL Humira.
Source: Drug Development Technology - Category: Pharmaceuticals Source Type: news